• Subscribe
  • Magazine
  • Past Issues
  • Surveys
  • Industry Statistics
  • About Us
  • Members Only
  • Best Places to Work
    • Recent Quotes
    My Watchlist
    Indicators
    PennEnergy Stock Watch
    Markets
    Stocks
    ETFs
    Tools
    Overview
    News
    Currencies
    International
    Treasuries

    Poseida Therapeutics Inc (NQ: PSTX )

    2.900 -0.070 (-2.36%)
    Streaming Delayed Price Updated: 4:00 PM EDT, Sep 27, 2024 Add to My Watchlist
    Quote
    Overview Detailed Quote Charting Historical Prices
    News
    All News News Headlines Press Releases
    Research
    Quarterly Reports Insider Filings Other Filings

    Price and Volume

    Detailed Quote
    Volume 808,400
    Open 3.020
    Bid (Size) 2.900 (15)
    Ask (Size) 2.930 (10)
    Prev. Close 2.970
    Today's Range 2.860 - 3.020
    52wk Range 1.830 - 4.270
    Shares Outstanding 86,916,199
    Dividend Yield N/A
    Chart for (: )
    Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

    Top News

    More News
    PSTX Stock Earnings: Poseida Therapeutics Beats EPS, Beats Revenue for Q2 2024
    PSTX stock results show that Poseida Therapeutics beat analyst estimates for earnings per share and beat on revenue for the second quarter of 2024. 
    Via InvestorPlace
    12 Health Care Stocks Moving In Tuesday's After-Market Session
    Via Benzinga

    Performance

    YTD
    -14.20%
    -14.20%
    1 Month
    +1.40%
    +1.40%
    3 Month
    -3.65%
    -3.65%
    6 Month
    -6.45%
    -6.45%
    1 Year
    +26.64%
    +26.64%

    More News

    Read More
    PSTX Stock Earnings: Poseida Therapeutics Beats EPS, Beats Revenue for Q1 2024
    Via InvestorPlace
    12 Health Care Stocks Moving In Tuesday's Pre-Market Session
    Via Benzinga
    Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Tuesday
    Via InvestorPlace
    Poseida Therapeutics: Q1 Earnings Insights
    Via Benzinga
    Looking Into Poseida Therapeutics's Return On Capital Employed
    Via Benzinga
    12 Health Care Stocks Moving In Monday's After-Market Session
    Via Benzinga
    Why Mesoblast Shares Are Trading Higher By 13%? Here Are Other Stocks Moving In Monday's Mid-Day Session
    Via Benzinga
    Exposures Product Safety
    12 Health Care Stocks Moving In Monday's Intraday Session
    Via Benzinga
    EQT, Genie Energy And Other Big Stocks Moving Lower On Monday
    Via Benzinga
    Topics Stocks
    Exposures US Equities
    PSTX Stock Earnings: Poseida Therapeutics Beats EPS, Beats Revenue for Q4 2023
    Via InvestorPlace
    Poseida Therapeutics' New Treatment For Multiple Myeloma Shows Early Success In Clinical Trial
    Via Benzinga
    12 Health Care Stocks Moving In Monday's Pre-Market Session
    Via Benzinga
    Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Monday
    Via InvestorPlace
    Biotech Breakthroughs: 3 Revolutionary Stocks Redefining Healthcare
    Via InvestorPlace
    Biotechnology Breakthroughs: 3 Biotech Stocks That Could Make Early Investors Rich
    Via InvestorPlace
    12 Health Care Stocks Moving In Tuesday's After-Market Session
    Via Benzinga
    Why Cutera Shares Are Trading Lower By Around 22%? Here Are Other Stocks Moving In Wednesday's Session
    Via Benzinga
    12 Health Care Stocks Moving In Wednesday's Intraday Session
    Via Benzinga
    12 Health Care Stocks Moving In Monday's Intraday Session
    Via Benzinga
    Why Are Poseida Therapeutics Shares Moving Higher Today?
    Via Benzinga
    PayPal Unveils USD-Backed Stablecoin, Trucking Firm Yellow Corp Files For Bankruptcy, FDA Approves First Oral Treatment For Postpartum Depression: Today's Top Stories
    Via Benzinga
    Why Krystal Biotech Shares Are Trading Lower By 12%? Here Are Other Stocks Moving In Monday's Mid-Day Session
    Via Benzinga
    Why JAKKS Pacific Shares Are Trading Lower By 13%? Here Are Other Stocks Moving In Friday's Mid-Day Session
    Via Benzinga
    Data & News supplied by www.cloudquote.io
    Stock quotes supplied by Barchart
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the following
    Privacy Policy and Terms and Conditions.